Bipartisan senators introduced legislation Tuesday requiring country-of-origin labels for prescription drugs to address transparency concerns within the global pharmaceutical supply chain.
The Yellowhammer State positioned itself as a manufacturing powerhouse as domestic production fueled a surge in data center investments and infrastructure.
The bill would prevent the state from contracting with companies that "boycott" other state companies using environmental, social and governance standards.